[amebic liver abscesses in yaounde]

NLM AIDSLINE [Amebic liver abscesses in Yaounde] Njoya O; Ndam EC; Ngoue V; Sende CN; Service d'hepatogastro-enterologie;
November 30, 1999

Sante. 1999 Mar-Apr;9(2):119-22. Unique Identifier : AIDSLINE Until 1985, morbidity and mortality from amebic infections were high in sub-Saharan Africa (2). The aim of this work was to describe the clinical, diagnostic and prognostic aspects of amebic liver lesions in a large town in tropical Africa, seven years after the last study of this disease in the area. We studied 96 amebic liver abscesses in 77 patients in a study with prospective and retrospective components. The patients were aged 20 to 65 years and the diagnoses were made on the basis of clinical radiological and biological criteria. Most of the patients were men (3:1). The most frequent clinical signs and symptoms were: pain on (100%), fever (92.2%), enlarged right hypochondrium (89.6%), heptomegaly (45.4%) and weight loss (39.6%). Ultrasound scans showed that the abscesses were most frequently found in the liver, on the right-hand side (65.6%) and that they were 20 to 125 mm in diameter. Between 80 and 2,500 ml of pus was drained from each abscess. We found pleuropulmonary lesions in 10.4% of cases. Serological tests for amebae were strongly positive in almost all cases and HIV tests (carried out prospectively) were positive in 11.6% of cases. The amebic liver lesions appeared to be primary in 66% of cases. The patients were treated with metronidazole, combined if necessary, with drainage under ultrasound surveillance. Two of the patients died. The others were completely cured after a mean of 13 days in hospital. Amebic infestations are cosmopolitan in nature. They occur most frequently in tropical areas. Amebic infections are rife in tropical Africa, with a prevalence of 1 to 2% (1). Liver amebiasis is the principal form of amebic infection outside of the intestine. Liver amebiasis is often detected at the stage of abscess formation. JOURNAL ARTICLE Adult Age Factors Aged Amebicides/THERAPEUTIC USE Anti-Infective Agents/THERAPEUTIC USE Cameroon/EPIDEMIOLOGY Comparative Study Diagnosis, Differential Drainage English Abstract Female Human Liver Abscess, Amebic/DIAGNOSIS/*EPIDEMIOLOGY/THERAPY Male Metronidazole/THERAPEUTIC USE Middle Age Prospective Studies Retrospective Studies Sex Factors

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common TAIWAN: Statins Tied to Lowered Liver Cancer Risk with Hepatitis C UNITED STATES: HIV Speeds Up Liver Disease in HCV Rapid pace of liver damage in recent HCV co-infection CALIFORNIA: Researchers Find Clue to How Hepatitis C Virus Harms Liver UNITED STATES: Highlights from the Liver Meeting Sorafenib for liver cancer in HIV co-infection Efficacy and Safety Data from Phase 2B Trials of Janssen's Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases Inovio Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV in Liver CALIFORNIA: African American Women with HIV, HCV Less Likely to Die from Liver Disease
Information in this article was accurate in November 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.